TY - JOUR A1 - Höh, Robert Benedikt A1 - Preißer, Felix A1 - Wenzel, Mike A1 - Humke, Clara Julia A1 - Wittler, Clarissa A1 - Hohenhorst, Jan L. A1 - Volckmann-Wilde, Maja A1 - Köllermann, Jens A1 - Steuber, Thomas A1 - Graefen, Markus A1 - Tilki, Derya A1 - Karakiewicz, Pierre I. A1 - Becker, Andreas A1 - Kluth, Luis A1 - Chun, Felix A1 - Mandel, Philipp T1 - Correlation of urine loss after catheter removal and early continence in men undergoing radical prostatectomy T2 - Current oncology N2 - Background: To determine the correlation between urine loss in PAD-test after catheter removal, and early urinary continence (UC) in RP treated patients. Methods: Urine loss was measured by using a standardized, validated PAD-test within 24 h after removal of the transurethral catheter, and was grouped as a loss of <1, 1–10, 11–50, and >50 g of urine, respectively. Early UC (median: 3 months) was defined as the usage of no or one safety-pad. Uni- and multivariable logistic regression models tested the correlation between PAD-test results and early UC. Covariates consisted of age, BMI, nerve-sparing approach, prostate volume, and extraprostatic extension of tumor. Results: From 01/2018 to 03/2021, 100 patients undergoing RP with data available for a PAD-test and early UC were retrospectively identified. Ultimately, 24%, 47%, 15%, and 14% of patients had a loss of urine <1 g, 1–10 g, 11–50 g, and >50 g in PAD-test, respectively. Additionally, 59% of patients reported to be continent. In multivariable logistic regression models, urine loss in PAD-test predicted early UC (OR: 0.21 vs. 0.09 vs. 0.03; for urine loss 1–10 g vs. 11–50 g vs. >50 g, Ref: <1 g; all p < 0.05). Conclusions: Urine loss after catheter removal strongly correlated with early continence as well as a severity in urinary incontinence. KW - functional outcome KW - incontinence KW - pad-test KW - radical prostatectomy KW - urinary incontinence Y1 - 2021 UR - http://publikationen.ub.uni-frankfurt.de/frontdoor/index/index/docId/81821 UR - https://nbn-resolving.org/urn:nbn:de:hebis:30:3-818218 SN - 1718-7729 VL - 28 IS - 6 SP - 4738 EP - 4747 PB - Multimed CY - Toronto, Ontario ER -